RxDoctor Payments Data

Tariq Arain

Family Medicine · Lancaster, KYNPI 1215979711

Payments from drug & device makers

$2,377in general payments, 2019–2025

Across 129 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$572
  • AstraZeneca$495
  • AbbVie$451
  • Boehringer Ingelheim$178
  • Novartis$123
  • Sanofi Pasteur Inc.$107
  • plus $451 from 15 others

What the payments were for

  • Food & beverage$2,377100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,377 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$12,029
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen53$530
Gabapentin65$479
Albuterol Sulfate HfaAlbuterol Sulfate15$459
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl33$446
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$344
Acetaminophen-CodeineAcetaminophen With Codeine12$246
Lisinopril40$217
Omeprazole22$157
Levothyroxine Sodium26$148
Atorvastatin Calcium32$148
Ibuprofen18$140
FenofibrateFenofibrate Nanocrystallized16$132
Quetiapine Fumarate16$105
Escitalopram Oxalate14$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$41$12,02912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Lancaster

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →